Tumor necrosis factor alpha transcription in macrophages is attenuated by an autocrine factor that preferentially induces NF-κB p50

Molecular and Cellular Biology

Volumn 18, Issue 10, 1998, Pages 5678-5689

  Baer, Mark ^a   Dillner, Allan ^a   Schwartz, Richard C ^a   Sedon, Constance ^a   Nedospasov, Sergei ^b,c   Johnson, Peter F ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Michigan State University ^*  (United States)

^c MOSCOW STATE UNIVERSITY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOCRINE MOTILITY FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; FIBROBLAST; GENE REPRESSION; MACROPHAGE ACTIVATION; MOUSE; NEGATIVE FEEDBACK; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RECEPTOR AFFINITY; REPORTER GENE; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANIMALIA; BACTERIA (MICROORGANISMS);

EID: 0031684844     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/mcb.18.10.5678     Document Type: Article

References (58)

1. Akira, S., H. Isshiki, T. Sugita, O. Tanabe, S. Kinoshita, Y. Nishio, T. Nakajima, T. Hirano, and T. Kishimolo. 1990. A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family. EMBO J. 9:1897-1906.
2. Akira, S., T. Taga, and T. Kishimoto. 1993. InterIeukin-6 in biology and medicine. Adv. Immunol. 54:1-78.
3. Baer, M., S. C. Williams, R. C. Schwartz, A. J. Dillner, and P. F. Johnson. Autocrine signals control C/EBPβ expression, localization, and activity in macrophages. Blood, in press.
4. Beyaert, R., and W. Fiers. 1994. Molecular mechanisms of tumor necrosis factor-induced cytotoxicity. What we do understand and what we do not. FEBS Lett. 340:9-16.
5. Bogdan, C., J. Paik, Y. Vodovotz, and C. Nathan. 1992. Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-β and interleukin-10. J. Biol Chem. 267:23301-23308.
6. Bonnerot, C., D. Rocancourt, P. Briand, G. Grimber, and J. F. Nicolas. 1987. A β-galactosidase hybrid protein targeted to nuclei as a marker for developmental studies. Proc. Natl. Acad. Sci. USA 84:6795-6799.
7. Bootcov, M. R., A. R. Bauskin, S. M. Valenzuela, A. G. Moore, M. Bansal, X. Y. He, H. P. Zhang, M. Donnellan, S. Mahler, K. Pryor, B. J. Walsh, R. C. Nicholson, W. D. Fairlie, S. B. Por, J. M. Robbins, and S. N. Breit. 1997. MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-β superfamily. Proc. Natl. Acad. Sci. USA 94:11514-11519.
8. Bretz, J. D., S. C. Williams, M. Baer, P. F. Johnson, and R. C. Schwartz. 1994. C/EBP-related protein 2 confers lipopolysaccharide-inducible expression of interleukin-6 and monocyte chemoattractant protein-1 to a lymphoblastic cell line. Proc. Natl. Acad. Sci. USA 91:7306-7310.
9. Brown, M. C., G. D. Tomaras, M. P. Vincenti, and S. M. Taffet. 1997. Two forms of NF-κB1 (p105/p50) in murine macrophages: differential regulation by lipopolysaccharide, interleukin-2, and interferon-γ. J. Interferon Cytokine Res. 17:295-306.
10. Caput, D., B. Beutler, K. Hartog, R. Thayer, S. Brown-Shinier, and A. Cerami. 1986. Identification of a common nucleotide sequence in the 3′-untranslated region of mRNA molecules specifying inflammatory mediators. Proc. Natl. Acad. Sci. USA 83:1670-1674.
11. Cleveland, D. W., M. A. Lopata, R. J. MacDonald, M. J. Cowan, W. J. Rutter, and M. W. Kirschner. 1980. Number and evolutionary conservation of αand β-tubulin and cytoplasmic β- and γ-actin genes using specific cloned cDNA probes. Cell 20:95-105.
12. Cox, G. W., B. J. Mathieson, L. Gandino, E. Blasi, D. Radzinch, and L. Varesio. 1989. Heterogeneity of hematopoietic cells immortalized by v-myc/ v-raf recombinant retrovirus infection of bone marrow or fetal liver. J. Natl. Cancer Inst. 81:1492-1496.
13. Dawe, C. J., and M. Potter. 1957. Morphologic and biologic progression of a lymphoid neoplasm of the mouse in vivo and in vitro. Am. J. Pathol. 33:603.
14. de Waal Malefyt, R., J. Abrams, B. Bennett, C. G. Figdor, and J. E. de Vries. 1991. Interleukin-10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174: 1209-1220.
15. Drouet, C., A. N. Shakhov, and C. V. Jongeneel. 1991. Enhancers and transcription factors controlling the inducibility of the tumor necrosis factor-α promoter in primary macrophages. J. Immunol. 147:1694-1700.
16. Espevik, T., I. S. Figari, M. R. Shalaby, G. A. Lackides, G. D. Lewis, H. M. Shepard, and M. A. Palladino, Jr. 1987. Inhibition of cytokine production by cyclosporin A and transforming growth factor β. J. Exp. Med. 166:571-576.
17. Fahmi, H., and R. Chaby. 1993. Selective refractoriness of macrophages to endotoxin-induced production of tumor necrosis factor, elicited by an autocrine mechanism. J. Leukoc. Biol. 53:45-52.
18. Fiorentino, D. F., A. Zlotnik, T. R. Mosmann, M, Howard, and A. O'Garra. 1991. IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 147:3815-3822.
19. Frankenberger, M., H. Pechumer, and H. W. Ziegler-Heitbrock. 1995. Interleukin-10 is upregulated in LPS tolerance. J. Inflamm. 45:56-63.
20. Fried, M., and D. M. Crothers. 1981. Equilibria and kinetics of lac repressoroperator interactions by polyacrylamide gel electrophoresis. Nucleic Acids Res. 9:6505-6525.
21. Garner, M. M., and A. Revzin. 1981. A gel electrophoresis method for quantifying the binding of proteins to specific DNA regions: application to components of Escherichia coli lactose operon regulatory system. Nucleic Acids Res. 9:3047-3060.
22. Hamilton, J. A. 1993. Colony stimulating factors, cytokines and monocytemacrophages - some controversies. Immunol. Today 14:18-24.
23. Hart, P. H., G. F. Vitti, D. R. Burgess, G. A. Whitty, D. S. Piccoli, and J. A. Hamilton. 1989. Potential antiinflammatory effects of interleukin 4: suppression of human monocyte tumor necrosis factor α, interleukin 1, and prostaglandin E2. Proc. Natl. Acad. Sci. USA 86:3803-3807.
24. Kang, S. M., A. C. Tran, M. Grilli, and M. J. Lenardo. 1992. NF-κB subunit regulation in nontranstormed CD4+ T lymphocytes. Science 256:1452-1456.
25. Kieran, M., V. Blank, F. Logeat, J. Vandekerckhove, F. Lottspeich, O. Le Bail, M. B. Urban, P. Kourilsky, P. A. Baeuerle, and A. Israel. 1990. The DNA binding subunit of NF-κB is identical to factor KBF1 and homologous to the rel oncogene product. Cell 62:1007-1018.
26. Kingston, R. E., P. Chomczynski, and N. Sacchi. 1991. Guanidium methods for total RNA preparation, p. 4.2.1-4.2.8. In F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.), Current protocols in molecular biology. Greene Publishing and Wiley-Inter-science, New York, N.Y.
27. Kunsch, C., and C. A. Rosen. 1993. NF-κB subunit-specific regulation of the interleukin-8 promoter. Mol. Cell. Biol. 13:6137-6146.
28. Kunsch, C., S. M. Ruben, and C. A. Rosen. 1992. Selection of optimal κB/Rel DNA-binding motifs: interaction of both subunits of NF-κB with DNA is required for transcriptional activation. Mol. Cell. Biol. 12:4412-4421.
29. 28a.Kuprash, D. V., I. A. Udalova, and S. Nedospasov. Unpublished data.
30. Kuprash, D. V., I. A. Udalova, R. L. Turetskaya, N. R. Rice, and S. A. Nedospasov. 1995. Conserved kappa B element located downstream of the tumor necrosis factor alpha gene: distinct NF-kappa B binding pattern and enhancer activity in LPS activated murine macrophages. Oncogene 11:97-106.
31. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
32. Ledebur, H. C., and T. P. Parks. 1995. Transcriptional regulation of the intercellular adhesion molecule-1 gene by inflammatory cytokines in human endothelial cells. Essential roles of a variant NF-κB site and p65 homodimers. J. Biol. Chem. 270:933-943.
33. Learning, N., D, Thanos, J. M. Brickman, J. Ma, T. Maniatis, and M. Plashne. 1994. An HMG-like protein that can switch a transcriptional activator to a represser. Nature 371:175-179.
34. Meda, M., M. A. Cassatella, G. I. Szendrel, L. Otvos, Jr., P. Baron, M. Villalba, D. Ferrari, and F. Rosel. 1995. Activation of microglial cells by β-amyloid and interferon-γ. Nature 374:647-650.
35. Nordeen, S. K. 1988. Luciferase reporter gene vectors for analysis of promoters and enhancers. BioTechniques 6:454-457.
36. Oeth, P. A., G. C. Parry, C. Kunsch, P. Nantermet, C. A. Rosen, and N. Mackman. 1994. Lipopolysaccharide induction of tissue factor gene expression in monocytic cells is mediated by binding of c-Rel/p65 heterodimers to a κB-like site. Mol. Cell. Biol. 14:3772-3781.
37. Ohmori, Y., J. Tebo, S. Nedospasov, and T. A. Hamilton. 1994. Kappa B binding activity in a murine macrophage-like cell line. Sequence-specific differences in kappa B binding and transcriptional activation functions. J. Biol. Chem. 269:17684-17690.
38. Pauli, U. 1994. Control of tumor necrosis factor gene expression. Crit. Rev. Eukaryotic Gene Expr. 4:323-344.
39. Renz, H., J. H. Gong, A. Schmidt, M. Nain, and D. Gemsa. 1988. Release of tumor necrosis factor-alpha from macrophages. Enhancement and suppression are dose-dependently regulated by prostaglandin E2 and cyclic nucleotides. J. Immunol. 141:2388-2393.
40. Rice, N. R., and M. K. Ernst. 1993. In vivo control of NF-κB activation by IκBα. EMBO J. 12:4685-4695.
41. Rice, N. R., M. L. MacKichan, and A. Israel. 1992. The precursor of NF-κB p50 has IκB-like functions. Cell 71:243-253.
42. Scales, W. E., S. W. Chensue, I. Otterness, and S. L. Kunkel. 1989. Regulation of monokine gene expression: prostaglandin E2 suppresses tumor necrosis factor but not interleukin-1 alpha or beta-mRNA and cell-associated bioactivity. J. Leukoc. Biol. 45:416-421.
43. Schattner, A. 1994. Short analytical review. Lymphokines in autoimmunity - a critical review. Clin. Immunol. Immunopathol. 70:177-189.
44. Schmilz, M. L., and P. A. Baeuerle. 1991. The p65 subunit is responsible for the strong transcription activating potential of NF-κB. EMBO J. 10:3805-3817.
45. Sen, R., and D. Baltimore. 1986. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 46:705-716.
46. Shakhov, A. N., M. A. Collart, P. Vassalli, S. A. Nedospasov, and C. V. Jongeneel. 1990. κB-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor a gene in primary macrophages. J. Exp. Med. 171:35-47.
47. Spengler, R. N., M. L. Spengler, P. Lincoln, D. G. Remick, R. M. Stricter, and S. L. Kunkel. 1989. Dynamics of dibutyryl cyclic AMP- and prostaglandin E2-mediated suppression of lipopolysaccharide-induced tumor necrosis factor alpha gene expression. Infect. Immun. 57:2837-2841.
48. Stone, R. 1994. Search for sepsis drugs goes on despite past failures. Science 264:365-367.
49. Sweet, M. J., and D. A. Hume. 1996. Endotoxin signal transduction in macrophages. J. Leukoc. Biol. 60:8-26.
50. Tracey, K. J., and A. Cerami. 1994. Tumor necrosis factor: a pleiotropic cytokine and therapeutic target Annu. Rev. Med. 45:491-503.
51. Trede, N. S., A. V. Tsytsykova, T. Chatila, A. E. Goldfeld, and R. S. Geha. 1995. Transcriptional activation of the human TNF-α promoter by superantigen in human monocytic cells: role of NF-κB. J. Immunol. 155:902-908.
52. Walker, W. S., and A. Demus. 1975. Antibody-dependent cytolysis of chicken erythrocytes by an in vitro-established line of mouse peritoneal macrophages. J. Immunol. 114:765-769.
53. Wang, P., P. Wu, J. C. Anthes, M. I. Siegel, R. W. Egan, and M. M. Billah. 1994. Interleukin-10 inhibits interleukin-8 production in human neutrophils. Blood 83:2678-2683.
54. Wang, P., P. Wu, M. I. Siegel, R. W. Egan, and M. M. Billah. 1994. IL-10 inhibits transcription of cytokine genes in human peripheral blood mononuclear cells. J. Immunol. 153:811-816.
55. Watanabe, N., T. Iwamura, T. Shinoda, and T. Fujita. 1997. Regulation of NFKB1 proteins by the candidate oncoprotein BCL-3: generation of NF-κB homodimers from the cytoplasmic pool of p50-p105 and nuclear translocation. EMBO J. 16:3609-3620.
56. Yao, J., N. Mackman, T. S. Edgington, and S. T. Fan. 1997. Lipopolysaccharide induction of the tumor necrosis factor-α promoter in human monocytic cells. Regulation by Egr-1, c-Jun, and NF-κB transcription factors. J. Biol. Chem. 272:17795-17801.
57. Ziegler-Heitbrock, H. W. 1995. Molecular mechanism in tolerance to lipopolysaccharide. J. Inflamm. 45:13-26.
58. Ziegler-Heitbrock, H. W., A. Wedel, W. Schraut, M. Strobel, P. Wendelgass, T. Sternsdorf, P. A. Bauerle, J. G. Haas, and G. Riethmuller. 1994. Tolerance to lipopolysaccharide involves mobilization of nuclear factor κB with predominance of p50 homodimers. J. Biol. Chem. 269:17001-17004.